According to Vericel 's latest financial reports the company's current earnings are A$0.23 Billion. In 2024 the company made an earning of A$17.07 Million, an increase over its 2023 earnings that were of -A$2.72 Million. The earnings displayed on this page is the company's Pretax Income.
Year | Earnings | Change |
---|---|---|
2025 (TTM) | A$6.69 M | -60.8% |
2024 | A$17.07 M | -729.19% |
2023 | -A$2.72 Million | -88.68% |
2022 | -A$23.98 Million | 106.12% |
2021 | -A$11.64 Million | -348.49% |
2020 | A$4.68 M | -131.58% |
2019 | -A$14.82 Million | 50.77% |
2018 | -A$9.83 Million | -60.41% |
2017 | -A$24.83 Million | -15.96% |
2016 | -A$29.55 Million | 17.89% |
2015 | -A$25.07 Million | -17.99% |
2014 | -A$30.56 Million | 27.56% |
2013 | -A$23.96 Million | |
2011 | -A$44.57 Million | |
2009 | -A$25.17 Million | -11.13% |
2008 | -A$28.32 Million | -12.47% |
2007 | -A$32.36 Million | 11.4% |
2006 | -A$29.05 Million | 23.76% |
2005 | -A$23.47 Million | 44.39% |
2004 | -A$16.26 Million | 3.56% |
2003 | -A$15.7 Million | 14.22% |
2002 | -A$13.74 Million | 11.76% |
2001 | -A$12.3 Million | 20.23% |
2000 | -A$10.23 Million | -41.62% |
1999 | -A$17.52 Million | -32.39% |
1998 | -A$25.91 Million | -1.07% |
1997 | -A$26.19 Million |
Company | Earnings | Earnings differencediff. | Country |
---|---|---|---|
![]() Royalty Pharma RPRX | A$3.09 B | 53,778.61% | ๐ฌ๐ง UK |
![]() Neogen NEOG | -A$0.79 Billion | -13,691.10% | ๐บ๐ธ USA |